CBUS vs SXT
CBUS: Cibus is a gene-editing biotechnology company that licenses proprietary agricultural productivity traits and develops sustainable plant-based ingredients for the global seed and consumer markets. SXT: Sensient Technologies is a leading developer and supplier of high-performance colors, flavors, and specialty ingredients that drive the taste, appearance, and functionality of consumer products worldwide.
Side-by-side fundamentals
| Metric | CBUS | SXT | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $1.81 | $124.93 | |
| Market cap as of 2026-07-30 | $147M | $5.3B | |
| P/E as of 2026-07-30 | n/a | 33.18 | |
| PEG as of 2026-07-30 | n/a | 2.04 | |
| Net margin as of 2026-07-30 | -2366.3% | +9.3% | SXT higher |
| Gross margin as of 2026-07-30 | +100.0% | +34.9% | CBUS higher |
| Operating margin as of 2026-07-30 | -1588.4% | +14.1% | SXT higher |
| ROE as of 2026-07-30 | -225.6% | +13.0% | SXT higher |
| ROA as of 2026-07-30 | -31.1% | +6.9% | SXT higher |
| Debt / equity as of 2026-07-30 | 6.89 | 0.61 | SXT lower |
| Revenue growth (YoY) as of 2026-07-30 | -9.8% | +8.1% | SXT higher |
| Revenue CAGR (3y) SEC XBRL | +185.1% | +3.9% | CBUS higher |
| Dividend yield as of 2026-07-30 | n/a | +1.3% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-30 | 1.67 | 0.78 | |
| 1-year return as of 2026-07-27 close | +12.4% | +10.3% | CBUS higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.